Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):119-28. doi: 10.1097/QAI.0000000000000919.

Abstract

Objective: Two distinct hypotheses have been proposed for T-cell involvement in protection from HIV-1 acquisition. First, HIV-1-specific memory T-cell responses generated on HIV-1 exposure could mount an efficient response to HIV-1 and inhibit the establishment of an infection. Second, a lower level of immune activation could reduce the numbers of activated, HIV-1-susceptible CD4 T cells, thereby diminishing the likelihood of infection.

Methods: To test these hypotheses, we conducted a prospective study among high-risk heterosexual men and women, and tested peripheral blood samples from individuals who subsequently acquired HIV-1 during follow-up (cases) and from a subset of those who remained HIV-1 uninfected (controls).

Results: We found no difference in HIV-1-specific immune responses between cases and controls, but Treg frequency was higher in controls as compared with cases and was negatively associated with frequency of effector memory CD4 T cells.

Conclusions: Our findings support the hypothesis that low immune activation assists in protection from HIV-1 infection.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • AIDS Vaccines / immunology
  • AIDS Vaccines / therapeutic use
  • Adult
  • Emtricitabine / therapeutic use
  • Female
  • HIV Infections / blood
  • HIV Infections / immunology*
  • HIV Infections / prevention & control*
  • HIV Infections / virology
  • HIV-1 / drug effects
  • HIV-1 / immunology*
  • Humans
  • Immunity, Cellular / drug effects
  • Immunity, Cellular / immunology
  • Lymphocyte Activation / drug effects
  • Lymphocyte Activation / immunology*
  • Male
  • Pre-Exposure Prophylaxis
  • Prospective Studies
  • T-Lymphocytes, Regulatory / drug effects
  • T-Lymphocytes, Regulatory / immunology*
  • Tenofovir / therapeutic use

Substances

  • AIDS Vaccines
  • Tenofovir
  • Emtricitabine